Skip to main content

Table 4 Associations with stratification by bilateral cases

From: Nuclear receptor coregulator SNP discovery and impact on breast cancer risk

SNP Genotypes Cases Controls OR 95% CI P
Cases bilateral
SRC-1 CC (%) 106 (93.8) 1432 (94.9) 1   
Rs1804645 CT (%) 6 (5.3) 77 (5.1) 1.05 0.44-2.47 0.906
P1272S TT (%) 1 (0.9) 0 (0.0) - - -
   [CT + TT]<-> [CC] 1.22 0.55-2.73 0.613
SRC-3 CC (%) 95 (86.4) 1330 (89.3) 1   
rs6094752 CT (%) 14 (12.7) 152 (10.2) 1.29 0.72-2.32 0.393
C218R TT (%) 1 (0.9) 8 (0.5) 1.75 0.22-14.14 0.595
   [CT + TT]<-> [CC] 1.31 0.74-2.32 0.347
SRC-3 GG (%) 88 (80.0) 1207 (80.3) 1   
Rs2230782 GC (%) 22 (20.0) 272 (18.1) 1.11 0.68-1.80 0.675
Q586H CC (%) 0 (0.7) 24 (1.6) 0.28 0.017-4.62 0.186
   [CC]<-> [GG + CT] 1.02 0.63-1.65 0.938
SRC-3 AA (%) 89 (80.2) 1240 (82.2) 1   
rs2076546 AG (%) 21 (18.9) 249 (16.5) 1.17 0.72-1.93 0.522
T960T GG (%) 1 (0.9) 20 (1.3) 0.69 0.09-5.25 0.724
   [AG + GG]<-> [AA] 1.14 0.70-1.85 0.597
SMRT GG (%) 79 (72.5) 1004 (67.6) 1   
rs2229840 AG (%) 27 (24.8) 423 (28.5) 0.81 0.52-1.27 0.363
A1706T AA (%) 3 (2.7) 57 (3.9) 0.67 0.20-2.18 0.502
   [AG + GG]<-> [AA] 0.79 0.51-1.23 0.298
  1. Odds ratios (OR) with 95% confidence intervals (95% CI) and P-values.